Dr.Muralidharan Anbalagan, PhD
Tulane University school of Medicine, USA.
  • Assistant Professor, Structural & Cellular Biology

  • Director, Pre-clinical small animal Imaging Facility

Dr. Anbalagan received his Ph.D. from the University of Madras, Tamilnadu, India in 2005. He conducted his doctoral studies on the pharmacological and toxicological properties of extracts isolated from Ocimum basilicum. He came to the U.S. in 2005 as a postdoctoral fellow at the University of Louisiana at Monroe, working on the molecular biology of prostate cancer and the role of calcitonin and its receptor. In 2007, Dr. Anbalagan joined Tulane University's  Department of Structural and Cellular Biology as a postdoc in Dr. Brian Rowan’s laboratory to investigate the effects of the novel peptidomimetic dual Src and pretubulin inhibitor KX-01 in experimental models of breast cancer. During this period, Dr. Anbalagan gained experience using mouse xenograft and bone metastatic cancer models, imaging small animals (bioluminescent, fluorescent, and X-Ray), and various molecular techniques. He is the director of the Small Animal Imaging Core (IVIS-XRMS) at Tulane Medical School.  In 2014, Dr. Anbalagan was promoted to an instructor and became Histology Lab Director for T1 medical students. Dr. Anbalagan has published over 20 peer-reviewed research articles and review papers. He is a reviewer for a variety of journals, including Cancer Letters, Journal of Pineal Research, Plos One, and Scientific Reports. In 2018, Dr. Anbalagan was promoted to assistant professor in the Department of Structural and Cellular Biology. In collaboration with the Tulane Circadian Biology Center, Dr. Anbalagan started to work on the circadian disruption of melatonin signal by dim light exposure at night and breast cancer metastasis to bone. He gained knowledge in bone biology by visiting Dr. Alexander Robling's bone research laboratory at Indiana University School of Medicine through a LACATS fellowship. Dr. Anbalagan is interested in understanding how estrogen receptor α (ERα) phosphorylation impacts bone development and bone turnover. His research will determine the role of ERα phosphorylation in bone homeostasis at young, adult and old ages.

Dr. D. Velmurugan, Ph.D.
The University of Madras. TN, India.

Dr. Velmurugan is a Professor, UGC-BSR Faculty, Former HoD, CAS in Crystallography and Biophysics & Former Coordinator, DBT- Bioinformatician at University of Madras, Guindy Campus, Chennai -25. During his career, he has developed many direct methods for Structure-based drug designing. His main interest is in crystal structure analysis of active compounds from herbal plants and Three-dimensional structure determination of small and macromolecules. It is notable that he has done his 4 years of post-doctoral studies under the Nobel Laureate (1985) Prof. H.A.Hauptman.

Dr. S. Gnanavel, Ph.D.
SRM Institute of Science and Technology, TN, India.

Dr. Gnanavel holds a Doctorate degree in Biomedical Engineering from SRM IST, Chennai. His area of research is mainly in Biomaterial and Artificial Organs, Nanocomposite, Biomedical Nanotechnology, Bio memes, Biosensors, and Tissue engineering.

Currently being an Assistant Professor at SRM Institute of Science & Technology, he has significantly contributed to the scientific fraternity by publishing numerous peer-reviewed research articles. He holds patents for his work in Bio-resin based artificial tongue prosthesis for taste recognition and oral hearing aids.